Related Experiment Videos
Nomifensine maleate: a new second-generation antidepressant
Clinical Pharmacy
|November 1, 1985
Summary
Nomifensine maleate is a safe and effective antidepressant, particularly for retarded depression, with a unique pharmacological profile. It offers advantages over traditional antidepressants due to its safety and minimal sedation.
Area of Science:
- Pharmacology
- Clinical Medicine
- Psychiatry
Background:
- Nomifensine maleate is an antidepressant medication.
- Its pharmacological profile includes potent inhibition of norepinephrine and dopamine reuptake.
- It has a unique action with little effect on serotonin reuptake.
Purpose of the Study:
- To review the pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, dosage, and formulary recommendations for nomifensine maleate.
- To evaluate nomifensine's effectiveness compared to standard antidepressants.
- To assess its safety profile and suitability for specific patient populations.
Main Methods:
- Review of existing pharmacological and clinical data.
- Analysis of clinical trial results comparing nomifensine to other antidepressants.
- Evaluation of adverse effects and toxicity data.
Main Results:
- Nomifensine is rapidly absorbed, widely distributed, and primarily eliminated by the kidneys.
- Clinical trials show it is as effective as traditional antidepressants like imipramine and amitriptyline.
- It is generally well-tolerated with few side effects and no serious toxicity in overdose.
Conclusions:
- Nomifensine maleate is a safe and effective antidepressant with a unique pharmacological profile.
- It is a good option for patients with retarded depression or intolerance to traditional antidepressants.
- Consideration for formulary addition is recommended due to its safety and low sedation.